Mitchell Green

Statistics

Publications

Citations

240

H-Index

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

General Atomics (United States)

Mitchell Green is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1998–2013

Publications

Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms

Kayo Sakaguchi, Mitchell Green, Nicholas Stock et al. · Archives of Biochemistry and Biophysics · 2004 · 111 citations

Life Sciences, Biochemistry, Chemistry +10

Aminopiperidine Sulfonamide Cav2.2 Channel Inhibitors for the Treatment of Chronic Pain

Pengcheng P. Shao, Feng Ye, Prasun K. Chakravarty et al. · Journal of Medicinal Chemistry · 2012 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

[45] Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: Methodology and mechanistic interpretations

Cynthia A. Earles, Hollie Wayment, Mitchell Green et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 1998 · 28 citations

Natural Sciences, Biochemistry, Electroanalytical Methods +12

A potent and selective indole N-type calcium channel (Cav2.2) blocker for the treatment of pain

Sriram Tyagarajan, Prasun K. Chakravarty, Min Park et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 23 citations · Full text

Medicine, Medicinal Chemistry, Pharmacotherapy +9

Improved Cav2.2 Channel Inhibitors through agem-Dimethylsulfone Bioisostere Replacement of a Labile Sulfonamide

Pengcheng P. Shao, Feng Ye, Prasun K. Chakravarty et al. · ACS Medicinal Chemistry Letters · 2013 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

1–5 of 7